Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pediatric Rule “Parts” To Be Cut In Light Of Exclusivity Provisions – Crawford

This article was originally published in The Tan Sheet

Executive Summary

FDA will decide which sections of its 1998 pediatric rule to keep and which to eliminate "over the next several weeks," FDA Acting Commissioner Lester Crawford, PhD, told the Senate Appropriations/ Agriculture Subcommittee March 20

You may also be interested in...



FDA Pediatric Rule “Usurps” Pediatric Exclusivity Law, Court Rules

The "command and control" approach of FDA's pediatric rule is "incompatible" with the Best Pharmaceuticals for Children Act, a Washington, D.C. federal judge ruled in striking down the agency reg

FDA Pediatric Rule “Usurps” Pediatric Exclusivity Law, Court Rules

The "command and control" approach of FDA's pediatric rule is "incompatible" with the Best Pharmaceuticals for Children Act, a Washington, D.C. federal judge ruled in striking down the agency reg

FDA Pediatric Rule “Usurps” Pediatric Exclusivity Law, Court Rules

The "command and control" approach of FDA's pediatric rule is "incompatible" with the Best Pharmaceuticals for Children Act, a Washington, D.C. federal judge ruled in striking down the agency reg

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093798

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel